These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28900606)

  • 1. Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia.
    Damlaj M; Ghazi S; Mashaqbeh W; Gmati G; Salama H; Abuelgasim KA; Rather M; Hajeer A; Al-Zahrani M; Jazieh AR; Alhejazi A; Alaskar A
    World J Transplant; 2017 Aug; 7(4):235-242. PubMed ID: 28900606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.
    Michelis FV; Messner HA; Loach D; Uhm J; Gupta V; Lipton JH; Seftel MD; Kuruvilla J; Kim DD
    Eur J Haematol; 2014 Oct; 93(4):273-80. PubMed ID: 24725056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
    Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
    Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplant.
    Thoma MD; Glejf J; Jacob E; Huneke TJ; DeCook LJ; Johnson ND; Patnaik MM; Litzow MR; Hogan WJ; Newell LF; Chandran R; Porrata LF; Holtan SG
    BMC Hematol; 2014; 14(1):14. PubMed ID: 25221674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia.
    Ishaqi MK; Afzal S; Dupuis A; Doyle J; Gassas A
    Bone Marrow Transplant; 2008 Feb; 41(3):245-52. PubMed ID: 17952129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant.
    Thoma MD; Huneke TJ; DeCook LJ; Johnson ND; Wiegand RA; Litzow MR; Hogan WJ; Porrata LF; Holtan SG
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):600-7. PubMed ID: 21843495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.
    Bayraktar UD; Milton DR; Guindani M; Rondon G; Chen J; Al-Atrash G; Rezvani K; Champlin R; Ciurea SO
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):505-13. PubMed ID: 26524730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
    Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR
    Bone Marrow Transplant; 2001 Nov; 28(10):951-6. PubMed ID: 11753550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.
    Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR
    Leukemia; 2003 Sep; 17(9):1865-70. PubMed ID: 12970788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions.
    Ortí G; Sanz J; García-Cadenas I; Sánchez-Ortega I; Alonso L; Jiménez MJ; Sisinni L; Azqueta C; Salamero O; Badell I; Ferra C; de Heredia CD; Parody R; Sanz MA; Sierra J; Piñana JL; Querol S; Valcárcel D
    Exp Hematol; 2018 Jun; 62():24-32. PubMed ID: 29526774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early lymphocyte recovery as a predictor of outcome, including relapse, after hematopoietic stem cell transplantation.
    Morando J; Fortier SC; Pasquini R; Zanis Neto J; Bonfim CM
    Rev Bras Hematol Hemoter; 2012; 34(6):430-5. PubMed ID: 23323067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma.
    Kim Y; Kim SJ; Cheong JW; Cho H; Chung H; Lee JY; Jang JE; Min YH; Kim JS
    Hematol Oncol; 2017 Dec; 35(4):465-471. PubMed ID: 27440113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute Lymphocyte Count Recovery Independently Predicts Outcome in Childhood Acute Lymphoblastic Leukemia: Experience From a Tertiary Care Cancer Center of a Developing Country.
    Gupta A; Kapoor G; Jain S; Bajpai R
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e143-9. PubMed ID: 26201035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT).
    Maffini E; Labopin M; Blaise D; Ciceri F; Gülbas Z; Deconinck E; Leblond V; Chevallier P; Sociè G; Araujo MC; Koc Y; Savani BN; Gorin NC; Lanza F; Nagler A; Mohty M
    Am J Hematol; 2020 Aug; 95(8):892-899. PubMed ID: 32303111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
    Yan CH; Liu QF; Wu DP; Zhang X; Xu LP; Zhang XH; Wang Y; Huang H; Bai H; Huang F; Ma X; Huang XJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1311-1319. PubMed ID: 28483716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different
    Sheth V; Kennedy V; de Lavallade H; Mclornan D; Potter V; Engelhardt BG; Savani B; Chinratanalab W; Goodman S; Greer J; Kassim A; York S; Kenyon M; Gandhi S; Kulasekararaj A; Marsh J; Mufti G; Pagliuca A; Jagasia M; Raj K
    Front Oncol; 2019; 9():623. PubMed ID: 31355140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.